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Abstract The rate of uptake of aspartate into the rat hepatoma
cell line H4-II-E-C3 is very much higher than that exhibited by
normal rat hepatocytes. Using an RT-PCR-based strategy, a
glutamate transporter resembling mouse liver GLT-1A has been
cloned from H4-II-E-C3 cells. Northern blotting confirmed that
relatively high levels of mRNA for GLT-1A are expressed in
hepatoma cells compared with negligible levels in rat hepato-
cytes. To our knowledge, this is the first report of the cloning of a
high-affinity glutamate transporter from a transformed cell line
and also the first demonstration of functional expression of GLT-
1 outside the central nervous system. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Glutamate transport across the plasma membrane into cells
is mediated by a family of high-a⁄nity sodium-dependent
transporter proteins termed system XAG3 . So far, ¢ve struc-
turally distinct members of this family have been cloned and
characterised. These all have similar kinetic properties and
have been termed GLAST (EAAT1), GLT-1 (EAAT2),
EAAC1 (EAAT3), EAAT4 and EAAT5. The pattern of indi-
vidual glutamate transporter expression in the central nervous
system (CNS) has been well characterised, and the metabolic
function of these transporters in brain is well understood (for
example see [1^3] for reviews).
In non-neuronal tissues, glutamate transporters are respon-
sible for the uptake of acidic amino acids across the brush
border membranes of epithelial cells, particularly in kidney,
intestine and in cell lines derived from epithelial tissues.
Where glutamate transporters have been cloned from such
cells and tissues, these have been universally found to be the
EAAC1. Expression of EAAC1 is highly regulated in some
cell types. For example in the bovine renal epithelial cell line
NBL-1, expression of EAAC1 activity is increased by both
hyperosmotic stress and amino acid starvation [4]. There are
few reports of expression of other glutamate transporters in
non-neuronal tissues. Evidence for expression of GLAST and
GLT-1 in human embryonic ¢broblasts has been reported
using £ow cytometry [5]. Furthermore a variant of GLT-1
has been found to be expressed at very low levels in mouse
liver by Northern blotting [6].
Little is known about glutamate transporter expression in
tumour cells. It has been shown previously [7] that the rat
hepatoma cell line H4-II-E-C3 expresses high rates of Na-
dependent glutamate transport although normal rat hepato-
cytes express negligible transport activity. In order to obtain
further information about changes in gene expression which
occur during liver cell transformation, we have established the
molecular identity of the glutamate transporter responsible for
this activity in this hepatoma cell line.
2. Materials and methods
H4-II-E-C3 cells were maintained subcon£uent in Hams nutrient F-
12 medium supplemented with 10% (v/v) foetal bovine serum (Life
Technologies, Paisley, UK), 2 mM glutamine and antibiotics as de-
scribed previously [8]. Cells were used for transport experiments when
they were approximately 80% con£uent on 35 mm culture dishes.
Transport experiments were performed as described previously [7].
Total RNA was prepared from cell cultures using Tri-reagent (Sig-
ma, Poole, UK) as per manufacturer’s instructions. First strand
cDNA was synthesised using oligo(dT)15 (Promega, Southampton,
UK) and used as a template for PCR ampli¢cation using appropriate
primers and Hi-Fidelity Taq polymerase according to the manufac-
turer’s instructions (Roche, East Sussex, UK). In some experiments, a
H4-II-E-C3 lambda-Zap II bacteriophage library from Stratagene
(Cambridge, UK) was used as a template for PCR. PCR products
were separated by agarose gel electrophoresis, gel-extracted (Qiaquick
spin kit, Qiagen, West Sussex, UK), ligated into pGEM T-Easy vector
(Promega) and used to transform CaCl2-competent E. coli. Plasmid
DNA was extracted (Genie II plasmid extraction kit, Helena Bioscien-
ces, Sunderland, UK) and subjected to automated sequencing (Ap-
plied Biosystems, Warrington, UK) using vector-speci¢c M13 primers.
The primers used were as follows: F1 5P-GG(A/G)GA(A/C)AC-
(C/T)CT(G/C)ATG(A/C)GGATGCTGAAG-3P ; F2 5P-GCTGGA-
ATTTTCCAAGCCTGGATCAC-3P ; R1 5P-GC(A/T)ATGAA(C/G)-
A(C/T)(A/G)GCTGCCACGGCTTC-3P ; R2 5P-GTATATTA(C/T)-
(A/T)T(G/C)TCCAC(G/C)ACC(A/G)TCATTGC-3P ; FullF 5P-CCC-
TCCTGTAGATAAGAGAATGGTCAG-3P ; FullR 5P-GCTGCAG-
GGGGTCTTTATTTTTCACG-3P ; T3 5P-AAGCTCGAAATTAA-
CCCTCACTAAAGGG-3P ; T7 5P-AGTGAATTGTAATACGACT-
CACTATAGGGC-3P.
For Northern analysis, total RNA prepared using Tri-reagent (Sig-
ma) was run on a 2.2 M formaldehyde agarose gel [9] and blotted
onto a nylon membrane (25 Wg/lane). A 300 bp probe prepared by
reverse transcription-PCR using primers F1 and R2 was labelled using
the Redi-prime radiolabelling kit (Amersham, Buckinghamshire, UK)
and [K-32P]dCTP. Prehybridisation and hybridisation were carried out
in a solution containing 45% formamide, 4USSPE (1USSPE contains
0.15 M NaCl, 10 mM sodium phosphate, 1 mM EDTA, pH 7.4),
0.1% sodium dodecyl sulfate (SDS), 5% (w/v) dextran sulphate and
50 Wg/ml sonicated salmon sperm DNA. Northern blots were probed
overnight at 42‡C. Blots were subsequently washed three times in
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0.5USSPE, 0.1% SDS at room temperature and a further three times
in 0.5USSPE, 0.1% SDS at 50‡C. Blots were then exposed to ¢lm.
3. Results
Fig. 1 shows a comparison between the initial rates of up-
take of L-aspartate in the hepatoma cell line H4-II-E-C3 and
in normal rat hepatocytes in short-term culture. The hepato-
ma cells exhibited high rates of Na-dependent aspartate
transport while no signi¢cant Na-dependent transport activ-
ity was present in the hepatocytes. Kinetic analysis of the
transport activity in hepatoma cells showed that aspartate
transport was competitively inhibited by L-glutamate and
D-aspartate but not signi¢cantly by D-glutamate. The Km for
L-aspartate was in the range 5^10 WM (not shown). These
results are consistent with transport via a member of the fam-
ily of cloned high-a⁄nity glutamate transporters. However,
unlike the glutamate transporter EAAC1 expressed in the bo-
vine renal epithelial cell line NBL-1 [4], the glutamate trans-
porter expressed in H4-II-E-C3 cells was insensitive to regu-
lation by hyperosmolarity or amino acid starvation (results
not shown).
Initially it was assumed that this transporter was EAAC1
since no other glutamate transporter had been shown to be
functionally expressed outside the CNS. However, extensive
attempts to clone EAAC1 by screening a commercial H4-II-E-
C3 cDNA library were unsuccessful, and no PCR products
corresponding to known EAAC1 sequences were obtained
using EAAC1-speci¢c primers and H4-II-E-C3 cDNA as tem-
plate. Members of the glutamate transporter family share sig-
ni¢cant regions of amino acid homology especially in trans-
membrane domains. Degenerate synthetic oligonucleotide
primers (F1 and R1, Fig. 2) were designed to homologous
sequences of rat brain EAAC1 and GLT-1. When these prim-
ers were used in PCR with H4-II-E-C3 cDNA as a template, a
product of about 980 bp was obtained which on sequencing
proved to be highly homologous to GLT-1, indicating that the
hepatoma cell line expressed a glutamate transporter similar
to GLT-1 rather than EAAC1
Fig. 2 illustrates the PCR cloning strategy used to obtain
the full-length coding region of H4-II-E-C3 GLT-1 and it
shows the positions of the primers used in relation to the
rat brain GLT-1 cDNA sequence [10]. The 990 bp product
(generated using primers F1 and R1) corresponds to bases
343^1333. A commercial H4-II-E-C3 lambda-Zap II bacterio-
phage cDNA library was used as a template for PCR. In this
library, insert sequences are £anked by T3 and T7 promoter
sequences. Primers corresponding to either T3 or T7 were
used as anchor primers together with gene-speci¢c primers
(F2 or R2) designed to the 990 bp cDNA sequence already
determined from H4-II-E-C3 cells in order to clone the 3P and
5P extremities of the molecule. The complete sequence was
con¢rmed by PCR through the entire coding region using
primers FullF and FullR. Three separate 1751 bp products
were sequenced in both directions.
The full-length cDNA sequence together with the derived
amino acid sequence is shown in the supplementary ¢le (annex
1) which accompanies this article on the FEBSLetters website.
The amino acid sequence is 94% similar to rat brain GLT-1
[10] and is greater than 99% identical to mouse liver GLT-1A
[6]. Comparing the rat hepatoma amino acid sequence with
the mouse liver GLT-1A sequence, there are ¢ve amino acid
changes at positions 23, 65, 210, 507 and 518 from glutamate,
alanine, leucine, histidine and valine in the H4-II-E-C3 pro-
tein to aspartate, serine, methionine, glutamine and isoleucine,
respectively. Additionally there is an extra threonine residue
at position 522 in the H4-II-E-C3 amino acid sequence which
is absent in mouse liver GLT-1A. These sequence changes
probably represent species di¡erences because identical
changes are observed between rat brain GLT-1 [10] and
mouse brain GLT-1 ([6], accession no. AB007810). Utsuno-
myia-Tate et al. [6] have expressed mouse liver GLT-1A in
Xenopus oocytes and shown that it encodes a functional so-
dium-dependent high-a⁄nity glutamate transporter. Since the
only amino acid di¡erences between mouse liver GLT-1A and
Fig. 1. Maximum rates of uptake of L-aspartate into H4-II-E-C3
hepatoma cells and rat hepatocytes. The hepatoma cells were incu-
bated with 50 mM [L-3H]aspartate in either Na- or choline-con-
taining medium in the presence of 0.5 mM amino-oxyacetate to in-
hibit transamination reactions. The reaction was stopped after 3 min
at room temperature; the uptake was linear with time over this pe-
riod. The results are the mean þ S.E.M. of values from ¢ve separate
culture dishes. The hepatocyte data are taken from [7]. Hepatocytes
were prepared by a standard collagenase perfusion technique [13].
Fig. 2. PCR cloning strategy for the hepatoma glutamate transporter. See explanation in the text.
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the rat hepatoma sequence are species-speci¢c, we can deduce
that the rat hepatoma cDNA sequence encodes a functional
glutamate transporter.
To determine the relative abundance of mRNA encoding
GLT-1A in hepatocytes and hepatoma cells, Northern blot
analysis using a 300 bp GLT-1-speci¢c probe was performed
on total RNA (Fig. 3). In rat hepatocytes and whole rat liver,
GLT-1A mRNA expression was undetectable under the con-
ditions used. However, under identical conditions, two dis-
tinct bands of 11 kb and 2.4 kb representing GLT-1A
mRNA were observed in H4-II-E-C3 cells. Additionally no
GLT-1 mRNA was detectable in the bovine renal epithelial
cell line NBL-1, the normal rat kidney epithelial cell line
(NRK) or the human placenta choriocarcinoma cell line
JAR, all of which are known to express high activities of
glutamate transport.
4. Discussion
The results presented in this paper show that the high rates
of Na-dependent aspartate transport observed in the rat
hepatoma cell line H4-II-E-C3 are due to the expression of
the rat analogue of mGLT-1A ¢rst cloned from mouse liver
[6]. This transporter is not expressed at a functional level in
isolated rat hepatocytes. To our knowledge, this is the ¢rst
report of the cloning of a high-a⁄nity glutamate transporter
from a transformed cell line; it is also the ¢rst demonstration
of the functional expression of GLT-1 from cells outside the
CNS. Expression of GLT-1A is not observed in a number of
other cell lines which express high rates of glutamate uptake
and may be speci¢c to cells derived from liver.
The physiological function of high-a⁄nity Na-dependent
glutamate transporter activity in tumour cells is not immedi-
ately obvious since these cells have a high internal concentra-
tion of glutamate derived from glutamine hydrolysis. Gluta-
mate e¥ux in exchange for cystine by system xc- is essential
for maintenance of intracellular glutathione levels [11]. Re-
uptake of glutamate by a high-a⁄nity glutamate transporter
has been proposed to maintain intracellular glutamate levels
and also to in£uence system xc- activity [12]. In support of
this, it has been shown that CHO-K1 cell mutants lacking
high-a⁄nity glutamate transport activity exhibit abnormally
low system xc- activity, possess lower levels of intracellular
glutathione and are more susceptible to damage by free rad-
icals and anti-cancer drugs [12].
Hepatoma cells exhibit increased growth rates, energy re-
quirements and altered metabolic pro¢les compared with nor-
mal hepatocytes. In principle, hepatoma cells can satisfy these
needs in one or more of the following ways: increased expres-
sion of normal liver genes; anomalous expression of genes
normally expressed in other tissues; or expression of novel
isoforms of proteins possessing altered properties. In the
case of high-a⁄nity glutamate transport, it appears that the
hepatoma cell line is upregulating expression of a gene which
is expressed at very low levels in normal liver. It remains to be
determined if upregulation of glutamate transport is an essen-
tial factor in cell transformation.
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Fig. 3. Northern blot of total RNA prepared form several sources
probed with 300 bp probe to GLT-1A. Loading of sample RNA is
as follows: 1: H4-II-E-C3 cells; 2: whole rat liver; 3: isolated rat
hepatocytes; 4: HepG2 cells; 5: JAR cells; 6: NBL-1 cells; 7:
NRK cells; 8: HEK 293 cells; 9: rat kidney.
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